Researchers Link Elevated PTH to High Uric Acid
Elevated serum parathyroid hormone levels are associated with higher serum uric acid levels in the U.S. adult population, investigators reported at ASN’s Renal Week 2009.
All articles by Eric Butterman
Specialty Pharmacy Improves Control of Secondary Hyperparathyroidism
Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN’s Renal Week 2009.
Cinacalcet Safely Treats Persistent Post-Kidney-Transplant Hyperparathyroidism
Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN’s Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.
Elevated Parathyroid Hormone Linked to Obesity in CKD Patients
Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN’s Renal Week 2009.
PTH Response to Calcitriol Reduced in African-American CKD Patients
Among patients with stages III-IV CKD, African-American race is associated with a decreased parathyroid hormone response to oral calcitriol, according to a study presented at ASN’s Renal Week 2009.
Loop Diuretics Raise Risk of Secondary Hyperparathyroidism
Loop diuretics increase the risk of secondary hyperparathyroidism in CKD patients, but concurrent use of thiazide diuretics attenuate that risk, data suggest according to a study that was presented at ASN’s Renal Week 2009.
Cinacalcet Effective for Refractory Hyperparathyroidism
Cinacalcet showed long-term efficacy in reducing serum parathyroid hormone and calcium levels in renal transplant patients with refractory tertiary hyperparathyroidism, according to a study presented at ASN’s Renal Week 2009.
Higher iPTH Does Not Hike Risk of Death, Cardiovascular Events
Higher intact parathyroid hormone levels are not associated with all-cause mortality and cardiovascular events in CKD patients not yet on dialysis, researchers have concluded in a study that was presented at Renal Week 2009.
Alfacalcidol Vs. Calcidol for Secondary Hyperparathyroidism
Oral alfacalcidol is effective in controlling secondary hyperparathyroidism with an adjusted dose 1.5 times that of oral calcitriol, a study showed.
Cinacalcet May Aid in Bone Remodeling After Renal Transplantation
Cinacalcet treatment following renal transplantation is associated with improved bone remodeling, a study found.
- Loading...
Loading...
Loading... 
Loading...